v2.4.0.6
Condensed Consolidated Statements of Income (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Revenues:        
Product $ 1,039,110 $ 975,757 $ 3,091,398 $ 2,839,562
Unconsolidated joint business 287,792 266,471 856,975 739,054
Other 58,652 67,706 150,147 143,308
Total revenues 1,385,554 1,309,934 4,098,520 3,721,924
Cost and expenses:        
Cost of sales, excluding amortization of acquired intangible assets 139,358 123,527 411,666 327,143
Research and development 304,217 301,391 989,738 880,668
Selling, general and administrative 299,631 261,398 901,488 772,217
Collaboration profit sharing 75,545 81,475 239,951 244,319
Amortization of acquired intangible assets 53,013 49,347 151,256 157,699
Fair value adjustment of contingent consideration 9,456 2,500 23,573 5,900
Restructuring charge 803 1,803 2,225 18,390
Total cost and expenses 882,023 821,441 2,719,897 2,406,336
Gain on sale of rights 31,719 0 31,719 0
Income from operations 535,250 488,493 1,410,342 1,315,588
Other income (expense), net (4,548) (7,727) 13,546 (9,504)
Income before income tax expense and equity in loss of investee, net of tax 530,702 480,766 1,423,888 1,306,084
Income tax expense 131,044 127,104 334,213 339,608
Equity in loss of investee, net of tax 1,258 0 1,769 0
Net income 398,400 353,662 1,087,906 966,476
Net income attributable to noncontrolling interests, net of tax 0 1,836 0 32,286
Net income attributable to Biogen Idec Inc. $ 398,400 $ 351,826 $ 1,087,906 $ 934,190
Net income per share:        
Basic earnings per share attributable to Biogen Idec Inc. $ 1.68 $ 1.45 $ 4.56 $ 3.85
Diluted earnings per share attributable to Biogen Idec Inc. $ 1.67 $ 1.43 $ 4.53 $ 3.81
Weighted-average shares used in calculating:        
Basic earnings per share attributable to Biogen Idec Inc. 236,474 242,883 238,331 242,266
Diluted earnings per share attributable to Biogen Idec Inc. 238,125 245,366 240,137 245,140